Acute ischemic stroke, Sublingual edaravone dexborneol, Brain cytoprotection agents, Randomized clinical trial
ticagrelor, clopidogrel, 1-year outcome, minor stroke, TIA
Multi-trajectory, Lipids, Premature cardiovascular disease, Residual risk, Cohort study